Trinomab(Zhuhai)

Zhuhai, China · Founded 2015 · In IPO Registration

Developer of antibody biopharmaceuticals designed for related medical research services. Trinomab(Zhuhai) is based in Zhuhai, China and was founded in 2015. Its last reported valuation was $534 million in Jun 2025. It has raised $221 million.

Last reported valuation

$533.7M

Oct 2026

Priced at

—

Total raised

$221.2M

Last round

—

How much has Trinomab(Zhuhai) raised?

$221.2Macross 0 recorded rounds

Free account

More of Trinomab(Zhuhai) with a free account

·The complete investor list: 27 names
·Watch Trinomab(Zhuhai): the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Trinomab(Zhuhai) investors

27 investors are on record for Trinomab(Zhuhai), including GL Ventures, CICC Capital, Shenzhen Guozhong Venture Capital Management and Guolian Investment. By type, the record holds 4 venture capital firms and 2 private equity firms.

For fundraisers

Raising for a company like Trinomab(Zhuhai)?

27 investors have backed Trinomab(Zhuhai).

See all 27 investors →

Frequently asked about Trinomab(Zhuhai)

How much has Trinomab(Zhuhai) raised?: Trinomab(Zhuhai) has raised $221.2M in total across 0 recorded funding rounds.